N
ERAS icon

Natixis’s Erasca ERAS Stock Holding History

Natixis’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-163,192
Closed -$2.64M – 1227
2026
Q1 		$2.64M Buy
+163,192
New +$1.93M 0.01% 544

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Natixis's ERAS Position: Q2 2026 in Review

Natixis sold out of Erasca (ERAS) in Q2 2026, closing a stake of 163,192 shares — an estimated $2.64M sold.

Natixis first reported a position in ERAS in Q1 2026 and held it in 1 quarter. The position peaked at $2.64M in Q1 2026. 256 funds tracked by Wall St. Rank hold ERAS as of Q2 2026.

  • Natixis reported no remaining Erasca position as of Q2 2026 after selling out during the quarter.
  • Natixis sold 163,192 Erasca shares in Q2 2026, an estimated $2.64M.
  • Natixis first reported a position in Erasca in Q1 2026 and held it in 1 quarter.
  • Natixis's Erasca position peaked at $2.64M in Q1 2026.
  • 256 funds tracked by Wall St. Rank held Erasca as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.